Aptevo Therapeutics (APVO) Net Income (2016 - 2022)
Historic Net Income for Aptevo Therapeutics (APVO) over the last 8 years, with Q4 2022 value amounting to $521000.0.
- Aptevo Therapeutics' Net Income rose 6030.77% to $521000.0 in Q4 2022 from the same period last year, while for Sep 2023 it was $521000.0, marking a year-over-year decrease of 3623.01%. This contributed to the annual value of -$18.6 million for FY2023, which is 194106.61% down from last year.
- Latest data reveals that Aptevo Therapeutics reported Net Income of $521000.0 as of Q4 2022, which was up 6030.77% from $165000.0 recorded in Q3 2022.
- Aptevo Therapeutics' Net Income's 5-year high stood at $5.2 million during Q3 2019, with a 5-year trough of -$12.9 million in Q2 2019.
- In the last 5 years, Aptevo Therapeutics' Net Income had a median value of $140500.0 in 2021 and averaged -$1.2 million.
- Over the last 5 years, Aptevo Therapeutics' Net Income had its largest YoY gain of 1313076.92% in 2019, and its largest YoY loss of 11733636.36% in 2019.
- Over the past 5 years, Aptevo Therapeutics' Net Income (Quarter) stood at $39000.0 in 2018, then soared by 4666.67% to $1.9 million in 2019, then crashed by 93.65% to $118000.0 in 2020, then skyrocketed by 175.42% to $325000.0 in 2021, then skyrocketed by 60.31% to $521000.0 in 2022.
- Its Net Income stands at $521000.0 for Q4 2022, versus $165000.0 for Q3 2022 and $149000.0 for Q2 2022.